We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
38 hedge funds and large institutions have $103M invested in scPharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
65% more funds holding
Funds holding: 23 → 38 (+15)
9% more capital invested
Capital invested by funds: $94.4M → $103M (+$8.79M)
0.66% more ownership
Funds ownership: 44.22% → 44.88% (+0.66%)
Holders
38
Holders Change
+15
Holders Change %
+65.22%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
8
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$3.86M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.16M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$934K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$651K |
| 5 |
AIC
AWM Investment Company
New York
|
+$648K |
